这是一篇来自已证抗体库的有关人类 KRT6A的综述，是根据97篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合KRT6A 抗体。
KRT6A 同义词: CK-6C; CK-6E; CK6A; CK6C; CK6D; K6A; K6C; K6D; KRT6C; KRT6D; PC3

赛默飞世尔
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100; 图 6b
赛默飞世尔 KRT6A抗体（eBioscience, 53-9003-82)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 6b). Commun Biol (2022) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 2, 4a, 4b
赛默飞世尔 KRT6A抗体（InVitrogen, MA5-13156)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 2, 4a, 4b). Mol Oncol (2022) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 2b
赛默飞世尔 KRT6A抗体（Lab Vision, MS-343-P)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 2b). Sci Adv (2021) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化; 犬; 图 2g
赛默飞世尔 KRT6A抗体（Zymed, D5/16B4)被用于被用于免疫组化在犬样本上 (图 2g). Animals (Basel) (2021) ncbi
小鼠 单克隆（AE1/AE3）
  • 流式细胞仪; 人类
赛默飞世尔 KRT6A抗体（eBioscience, 53-9003-82)被用于被用于流式细胞仪在人类样本上. Nat Commun (2021) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 图 4a
赛默飞世尔 KRT6A抗体（eBioscience, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4a). Proc Natl Acad Sci U S A (2020) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 猕猴; 0.2 ug/ml; 图 4g
赛默飞世尔 KRT6A抗体（Thermo Fisher, 41-9003-82)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为0.2 ug/ml (图 4g). Science (2020) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1a
赛默飞世尔 KRT6A抗体（eBioscience, 53-9003-80)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1a). Nat Cell Biol (2020) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类; 图 4, 5
赛默飞世尔 KRT6A抗体（eBioscience, AE1/AE3)被用于被用于免疫细胞化学在人类样本上 (图 4, 5). Breast Cancer Res (2019) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫细胞化学; 人类; 图 s1b
赛默飞世尔 KRT6A抗体（Thermo Fischer, MA5-13203)被用于被用于免疫细胞化学在人类样本上 (图 s1b). Sci Rep (2017) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:150; 表 2
赛默飞世尔 KRT6A抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (表 2). Hum Pathol (2017) ncbi
小鼠 单克隆（AE3）
  • 流式细胞仪; 人类
赛默飞世尔 KRT6A抗体（eBioscience, 14-900-80)被用于被用于流式细胞仪在人类样本上. F1000Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5b
赛默飞世尔 KRT6A抗体（Thermo, PA5-28235)被用于被用于免疫印迹在人类样本上 (图 5b). J Proteome Res (2017) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 图 3d
赛默飞世尔 KRT6A抗体（Thermo Scientific, AE1-AE3)被用于被用于免疫组化在人类样本上 (图 3d). Case Rep Pathol (2016) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 人类; 1:75; 表 2
赛默飞世尔 KRT6A抗体（Thermo Scientific, D5/16 B4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:75 (表 2). Hum Pathol (2017) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫细胞化学; 小鼠; 图 3c
  • 免疫印迹; 小鼠; 图 3d
赛默飞世尔 KRT6A抗体（Thermo Scientific, MA5-13203)被用于被用于免疫细胞化学在小鼠样本上 (图 3c) 和 被用于免疫印迹在小鼠样本上 (图 3d). Oncogene (2017) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 图 5b
赛默飞世尔 KRT6A抗体（Thermo Scientific, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上 (图 5b). Breast Cancer Res Treat (2016) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类; 1:50; 图 1
赛默飞世尔 KRT6A抗体（ThermoFisher Scientific, MA5-13156)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 1). Future Oncol (2016) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 图 s3
赛默飞世尔 KRT6A抗体（分子探针, 985542A)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s3). Microbiome (2015) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫组化-石蜡切片; 小鼠; 图 4
赛默飞世尔 KRT6A抗体（Thermo Scientific, MA5-13203)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4). Sci Rep (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:50; 图 3
赛默飞世尔 KRT6A抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 3). Pathol Res Pract (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 小鼠; 1:100; 表 2
赛默飞世尔 KRT6A抗体（eBioscience, 41-9003)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (表 2). J Cell Physiol (2016) ncbi
小鼠 单克隆（D5/I6 B4）
  • 免疫组化; 人类; ready to use
赛默飞世尔 KRT6A抗体（Thermo Scientific, MS-1814-R7)被用于被用于免疫组化在人类样本上浓度为ready to use. Pathol Res Pract (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 表 2
赛默飞世尔 KRT6A抗体（Thermo Scientific, AE1/AE3)被用于被用于免疫组化在人类样本上 (表 2). Diagn Cytopathol (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 鲤
赛默飞世尔 KRT6A抗体（生活技术, MA5-13156)被用于被用于免疫细胞化学在鲤样本上. In Vitro Cell Dev Biol Anim (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 流式细胞仪; 人类
  • 免疫细胞化学; 人类; 1 ul
赛默飞世尔 KRT6A抗体（eBioscience, 53-9003-82)被用于被用于流式细胞仪在人类样本上 和 被用于免疫细胞化学在人类样本上浓度为1 ul. Nanomedicine (2015) ncbi
小鼠 单克隆（C11）
  • 免疫印迹; 人类; 1:1000
赛默飞世尔 KRT6A抗体（Thermo Scientific, 4545)被用于被用于免疫印迹在人类样本上浓度为1:1000. BMC Cancer (2015) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫印迹; 人类
赛默飞世尔 KRT6A抗体（Thermo Fisher Scientific, MA5-13203)被用于被用于免疫印迹在人类样本上. Stem Cell Res Ther (2015) ncbi
小鼠 单克隆（AE1/AE3）
赛默飞世尔 KRT6A抗体（Invitrogen, AE1/AE3)被用于. In Vitro Cell Dev Biol Anim (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 10-20 ug/ml
赛默飞世尔 KRT6A抗体（Lab.Vision, Ab-1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 猫; 1:100
  • 免疫组化-石蜡切片; 犬; 1:100
赛默飞世尔 KRT6A抗体（Zymed, D5/16B4)被用于被用于免疫组化-石蜡切片在猫样本上浓度为1:100 和 被用于免疫组化-石蜡切片在犬样本上浓度为1:100. J Comp Pathol (2015) ncbi
小鼠 单克隆（AE3）
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 s6
赛默飞世尔 KRT6A抗体（Thermo, MS-34)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 s6). Nat Commun (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 s6
赛默飞世尔 KRT6A抗体（Thermo, MS-34)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 s6). Nat Commun (2015) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 KRT6A抗体（Thermo Scientific, clone D5/16 B4)被用于被用于免疫组化-石蜡切片在人类样本上. Am J Surg Pathol (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 5
赛默飞世尔 KRT6A抗体（ThermoFisher Scientific, AE1/AE3)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 5). Development (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT6A抗体（Neo Markers, MS343)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Comp Med (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3
赛默飞世尔 KRT6A抗体（eBioscience, 53-9003-80)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3). Nat Cell Biol (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT6A抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Hum Pathol (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT6A抗体（Thermo Fisher Scientific, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Rom J Morphol Embryol (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类
赛默飞世尔 KRT6A抗体（Invitrogen, AE1/AE3)被用于被用于免疫细胞化学在人类样本上. Histopathology (2015) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 KRT6A抗体（Thermo Scientific, D5/16 B4)被用于被用于免疫组化-石蜡切片在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类
赛默飞世尔 KRT6A抗体（Thermo, AE1/AE3)被用于被用于免疫组化在人类样本上. BMC Med Imaging (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类
赛默飞世尔 KRT6A抗体（Thermo Fisher, AE1/AE3)被用于被用于免疫细胞化学在人类样本上. Biomed Mater (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 KRT6A抗体（Thermoelectron, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上. BMC Med Imaging (2013) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化; 人类; 1:100
赛默飞世尔 KRT6A抗体（Zymed Laboratories, Clone D5/16B4)被用于被用于免疫组化在人类样本上浓度为1:100. Clin Transl Oncol (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
赛默飞世尔 KRT6A抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Sci Rep (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类; 1:100; 图 1
赛默飞世尔 KRT6A抗体（eBioscience, AE1/AE3)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1). PLoS ONE (2013) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 人类; 1:200; 图 2
赛默飞世尔 KRT6A抗体（Zymed, clone D5/16B4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 2). Int J Clin Exp Pathol (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 表 1
赛默飞世尔 KRT6A抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化在人类样本上 (表 1). Head Face Med (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 1:200; 图 4
赛默飞世尔 KRT6A抗体（Zymed, AE1-AE3)被用于被用于免疫组化在人类样本上浓度为1:200 (图 4). Surg Neurol Int (2013) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化; 人类; 表 3
赛默飞世尔 KRT6A抗体（生活技术, D5/16B4)被用于被用于免疫组化在人类样本上 (表 3). BMC Cancer (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 图 2
赛默飞世尔 KRT6A抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化在人类样本上 (图 2). Diagn Pathol (2013) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化; 人类; 图 2
赛默飞世尔 KRT6A抗体（Invitrogen, D5/16B4)被用于被用于免疫组化在人类样本上 (图 2). Diagn Pathol (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 大西洋鲑鱼; 1:50; 图 2
赛默飞世尔 KRT6A抗体（Invitrogen, AE1/AE3)被用于被用于免疫细胞化学在大西洋鲑鱼样本上浓度为1:50 (图 2). Virol J (2013) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 犬; 1:100
赛默飞世尔 KRT6A抗体（Zymed, D5/16B4)被用于被用于免疫组化-石蜡切片在犬样本上浓度为1:100. BMC Vet Res (2012) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 犬; 1:100; 表 2
赛默飞世尔 KRT6A抗体（Zymed, D5/16B4)被用于被用于免疫组化-石蜡切片在犬样本上浓度为1:100 (表 2). ScientificWorldJournal (2012) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT6A抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Med Sci Monit (2012) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠
赛默飞世尔 KRT6A抗体（Thermo Scientific, MS-343)被用于被用于免疫组化-石蜡切片在小鼠样本上. Anat Cell Biol (2011) ncbi
小鼠 单克隆（C-11）
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫细胞化学; 人类; 1:100
赛默飞世尔 KRT6A抗体（Labvision, MS-149)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫细胞化学在人类样本上浓度为1:100. Br J Cancer (2012) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 KRT6A抗体（Invitrogen, D5/16B4)被用于被用于免疫组化-石蜡切片在人类样本上. Int J Surg Pathol (2014) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫细胞化学; 人类; 表 1
赛默飞世尔 KRT6A抗体（Zymed, D5/16B4)被用于被用于免疫细胞化学在人类样本上 (表 1). In Vitro Cell Dev Biol Anim (2011) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 人类; 1:50; 图 2, 3, 4
赛默飞世尔 KRT6A抗体（Invitrogen, D5/16B4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 2, 3, 4). Int J Surg Pathol (2011) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化; 人类; 1:50
赛默飞世尔 KRT6A抗体（Zymed, D5)被用于被用于免疫组化在人类样本上浓度为1:50. Eur J Cancer (2010) ncbi
小鼠 单克隆（D5/I6 B4）
  • 免疫组化; 人类; 1:50
赛默飞世尔 KRT6A抗体（Zymed, D5)被用于被用于免疫组化在人类样本上浓度为1:50. Eur J Cancer (2010) ncbi
小鼠 单克隆（AE3）
  • 免疫组化-石蜡切片; 人类; 1:300; 表 2
赛默飞世尔 KRT6A抗体（Zymed, AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:300 (表 2). J Comp Pathol (2009) ncbi
小鼠 单克隆（C11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT6A抗体（Invitrogen, C-11)被用于被用于免疫印迹在小鼠样本上. Infect Immun (2009) ncbi
小鼠 单克隆（C-11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT6A抗体（Invitrogen, C-11)被用于被用于免疫印迹在小鼠样本上. Infect Immun (2009) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔 KRT6A抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Cancer (2008) ncbi
小鼠 单克隆（D5/16 B4）
  • 免疫组化-石蜡切片; 人类; 1:50; 表 1
赛默飞世尔 KRT6A抗体（Zymed, D5/16B4)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 1). J Clin Pathol (2008) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫印迹; 人类; 图 5
赛默飞世尔 KRT6A抗体（Lab Vision, MS-343-P)被用于被用于免疫印迹在人类样本上 (图 5). Int J Cancer (2005) ncbi
小鼠 单克隆（C11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT6A抗体（NeoMarkers, C-11)被用于被用于免疫印迹在小鼠样本上. Mol Cell Biol (2004) ncbi
小鼠 单克隆（C-11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT6A抗体（NeoMarkers, C-11)被用于被用于免疫印迹在小鼠样本上. Mol Cell Biol (2004) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:80; 表 1
赛默飞世尔 KRT6A抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:80 (表 1). Pathol Int (2004) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫印迹; 人类; 1:1000; 图 2
赛默飞世尔 KRT6A抗体（Zymed, AE1/AE3)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Gynecol Oncol (2003) ncbi
艾博抗（上海）贸易有限公司
小鼠 单克隆（Ks6.KA12）
  • 免疫组化; 小鼠; 图 2f
艾博抗（上海）贸易有限公司 KRT6A抗体（Abcam, Ab18586)被用于被用于免疫组化在小鼠样本上 (图 2f). iScience (2022) ncbi
小鼠 单克隆（Ks6.KA12）
  • 免疫组化-石蜡切片; 小鼠; 图 e3i
艾博抗（上海）贸易有限公司 KRT6A抗体（Abcam, Ks6.KA12)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 e3i). Nature (2019) ncbi
小鼠 单克隆（Ks6.KA12）
  • 免疫组化-石蜡切片; 小鼠; 1:10; 图 3b
艾博抗（上海）贸易有限公司 KRT6A抗体（Abcam, ab18586)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:10 (图 3b). Clin Sci (Lond) (2017) ncbi
小鼠 单克隆（Ks6.KA12）
  • 免疫组化; pigs ; 1:200
艾博抗（上海）贸易有限公司 KRT6A抗体（Abcam, ab18586)被用于被用于免疫组化在pigs 样本上浓度为1:200. J Mater Sci Mater Med (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆（SPM269）
  • 免疫组化; 小鼠; 图 4a
  • 免疫印迹; 小鼠; 1:1000; 图 5a
圣克鲁斯生物技术 KRT6A抗体（Santa Cruz Biotechnology, Sc-56373)被用于被用于免疫组化在小鼠样本上 (图 4a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Cells (2022) ncbi
小鼠 单克隆（LHK 6）
  • 免疫细胞化学; 人类; 图 2b
圣克鲁斯生物技术 KRT6A抗体（Santa Cruz, LHK6)被用于被用于免疫细胞化学在人类样本上 (图 2b). Sci Rep (2016) ncbi
小鼠 单克隆（LHK 6）
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 KRT6A抗体（Santa Cruz, sc-53260)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). BMC Res Notes (2016) ncbi
BioLegend
大鼠 单克隆（W17006B）
  • 免疫组化-石蜡切片; 人类; 1:200; 图 s1a
BioLegend KRT6A抗体（Biolegend, 606101)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 s1a). Int J Mol Sci (2022) ncbi
碧迪BD
小鼠 单克隆（CAM 5.2）
  • 免疫细胞化学; 人类; 10 ug/ml; 图 2b
碧迪BD KRT6A抗体（BD, CAM5.2)被用于被用于免疫细胞化学在人类样本上浓度为10 ug/ml (图 2b). BMC Cancer (2020) ncbi
单克隆（CAM5.2）
  • 免疫细胞化学; 人类; 10 ug/ml; 图 2b
碧迪BD KRT6A抗体（BD, CAM5.2)被用于被用于免疫细胞化学在人类样本上浓度为10 ug/ml (图 2b). BMC Cancer (2020) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫细胞化学; 人类; 图 4, 5
碧迪BD KRT6A抗体（BD Biosciences, CAM5.2)被用于被用于免疫细胞化学在人类样本上 (图 4, 5). Breast Cancer Res (2019) ncbi
单克隆（CAM5.2）
  • 免疫细胞化学; 人类; 图 4, 5
碧迪BD KRT6A抗体（BD Biosciences, CAM5.2)被用于被用于免疫细胞化学在人类样本上 (图 4, 5). Breast Cancer Res (2019) ncbi
单克隆（CAM5.2）
  • 免疫组化-石蜡切片; 人类; 图 4c
碧迪BD KRT6A抗体（BD Biosciences, 345779)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4c). J Histochem Cytochem (2018) ncbi
小鼠 单克隆（CAM 5.2）
  • 流式细胞仪; 人类; 15 ug/ml
碧迪BD KRT6A抗体（BD Biosciences, 347653)被用于被用于流式细胞仪在人类样本上浓度为15 ug/ml. Cell Death Dis (2017) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 人类; 图 s9b
碧迪BD KRT6A抗体（BD Bioscience, Cam5.2)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s9b). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 犬
  • 免疫组化; 犬; 图 84
碧迪BD KRT6A抗体（BD Biosciences, 349205)被用于被用于免疫组化-石蜡切片在犬样本上 和 被用于免疫组化在犬样本上 (图 84). J Toxicol Pathol (2017) ncbi
小鼠 单克隆（CAM 5.2）
  • 流式细胞仪; 食蟹猴; 图 4a
碧迪BD KRT6A抗体（BD Biosciences, CAM5.2)被用于被用于流式细胞仪在食蟹猴样本上 (图 4a). J Immunol (2017) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫细胞化学; 人类; 图 5a
碧迪BD KRT6A抗体（BD Biosciences, CAM5.2)被用于被用于免疫细胞化学在人类样本上 (图 5a). Cancer Res (2017) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫细胞化学; 人类; 1:600; 图 4
碧迪BD KRT6A抗体（BD Biosciences, BD-349205)被用于被用于免疫细胞化学在人类样本上浓度为1:600 (图 4). J Cancer (2016) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化; 人类
碧迪BD KRT6A抗体（BD Biosciences, CAM 5.2)被用于被用于免疫组化在人类样本上. Virchows Arch (2015) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化; 人类
碧迪BD KRT6A抗体（Becton Dickinson, CAM5.2)被用于被用于免疫组化在人类样本上. Int J Clin Exp Pathol (2015) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 人类; 图 3
碧迪BD KRT6A抗体（BD Biosciences, Cam5.2)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3). Nature (2015) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 人类
碧迪BD KRT6A抗体（Becton Dickinson, 349205)被用于被用于免疫组化-石蜡切片在人类样本上. Springerplus (2015) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 人类; 1:10
碧迪BD KRT6A抗体（BD Biosciences, CAM5.2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:10. Cytopathology (2016) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 人类; 1:1
碧迪BD KRT6A抗体（Becton Dickinson Immunocytometry Systems, Cam5.2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1. World J Gastroenterol (2015) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 人类; 1:20
碧迪BD KRT6A抗体（BD, Cam 5.2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20. Endocr Pathol (2014) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫细胞化学; 人类
碧迪BD KRT6A抗体（Beckton Dickinson, CAM5.2)被用于被用于免疫细胞化学在人类样本上. J Cancer (2014) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化-石蜡切片; 人类
碧迪BD KRT6A抗体（Becton-Dickinson, CAM5.2)被用于被用于免疫组化-石蜡切片在人类样本上. Oncol Lett (2014) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化; 犬
碧迪BD KRT6A抗体（Becton Dickinson, CAM5.2)被用于被用于免疫组化在犬样本上. J Comp Pathol (2014) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化; 人类
碧迪BD KRT6A抗体（Becton Dickinson, CAM5.2)被用于被用于免疫组化在人类样本上. Head Neck (2014) ncbi
小鼠 单克隆（CAM 5.2）
  • 免疫组化; 人类
碧迪BD KRT6A抗体（Becton, CAM 5.2)被用于被用于免疫组化在人类样本上. Development (2013) ncbi
文章列表
  1. Canesin G, Feldbr xfc gge L, Wei G, Janovičová Ľ, Janikova M, Csizmadia E, et al. Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1/Notch1 pathway in myeloid cells. iScience. 2022;25:104983 pubmed 出版商
  2. Bhattacharya N, INDRA A, Ganguli Indra G. Selective Ablation of BCL11A in Epidermal Keratinocytes Alters Skin Homeostasis and Accelerates Excisional Wound Healing In Vivo. Cells. 2022;11: pubmed 出版商
  3. Koliakou E, Eleni M, Koumentakou I, Bikiaris N, Konstantinidou P, Rousselle P, et al. Altered Distribution and Expression of Syndecan-1 and -4 as an Additional Hallmark in Psoriasis. Int J Mol Sci. 2022;23: pubmed 出版商
  4. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed 出版商
  5. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed 出版商
  6. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed 出版商
  7. Levi M, Muscatello L, Brunetti B, Benazzi C, Parenti F, Gobbo F, et al. High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome. Animals (Basel). 2021;11: pubmed 出版商
  8. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed 出版商
  9. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed 出版商
  10. Ortiz Otero N, Marshall J, Lash B, King M. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients. BMC Cancer. 2020;20:873 pubmed 出版商
  11. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed 出版商
  12. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed 出版商
  13. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed 出版商
  14. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed 出版商
  15. Kim J, Villadsen R. Expression of Luminal Progenitor Marker CD117 in the Human Breast Gland. J Histochem Cytochem. 2018;66:879-888 pubmed 出版商
  16. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed 出版商
  17. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed 出版商
  18. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed 出版商
  19. Fumagalli A, Drost J, Suijkerbuijk S, van Boxtel R, de Ligt J, Offerhaus G, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114:E2357-E2364 pubmed 出版商
  20. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed 出版商
  21. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed 出版商
  22. Irrera N, Vaccaro M, Bitto A, Pallio G, Pizzino G, Lentini M, et al. BAY 11-7082 inhibits the NF-?B and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis. Clin Sci (Lond). 2017;131:487-498 pubmed 出版商
  23. Wonderlich E, Swan Z, Bissel S, Hartman A, Carney J, O Malley K, et al. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol. 2017;198:1616-1626 pubmed 出版商
  24. Foster M, Gwinn W, Kelly F, Brass D, Valente A, Moseley M, et al. Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl. J Proteome Res. 2017;16:538-549 pubmed 出版商
  25. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  26. Day K, Lorenzatti Hiles G, Kozminsky M, Dawsey S, Paul A, Broses L, et al. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer Res. 2017;77:74-85 pubmed 出版商
  27. Hsieh M, Wang H, Lee Y, Ko J, Chang Y. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hum Pathol. 2017;61:9-18 pubmed 出版商
  28. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed 出版商
  29. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed 出版商
  30. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed 出版商
  31. Kokado M, Okada Y, Miyamoto T, Yamanaka O, Saika S. Effects of epiplakin-knockdown in cultured corneal epithelial cells. BMC Res Notes. 2016;9:278 pubmed 出版商
  32. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed 出版商
  33. Chen Y, Cheng B, He Z, Wang S, Wang Z, Sun M, et al. Capture and Identification of Heterogeneous Circulating Tumor Cells Using Transparent Nanomaterials and Quantum Dots-Based Multiplexed Imaging. J Cancer. 2016;7:69-79 pubmed 出版商
  34. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed 出版商
  35. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed 出版商
  36. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed 出版商
  37. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed 出版商
  38. KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed 出版商
  39. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed 出版商
  40. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed 出版商
  41. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed 出版商
  42. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed 出版商
  43. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed
  44. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed 出版商
  45. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed 出版商
  46. Drost J, van Jaarsveld R, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521:43-7 pubmed 出版商
  47. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed 出版商
  48. Campbell J, Miller D, Cundiff D, Feng Q, Litofsky N. Neural stem/progenitor cells react to non-glial cns neoplasms. Springerplus. 2015;4:53 pubmed 出版商
  49. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  50. Meykler S, Baloch Z, Barroeta J. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology. 2016;27:70-2 pubmed 出版商
  51. Muscatello L, Sarli G, Beha G, Asproni P, Millanta F, Poli A, et al. Validation of tissue microarray for molecular profiling of canine and feline mammary tumours. J Comp Pathol. 2015;152:153-60 pubmed 出版商
  52. Yamada S, Nabeshima A, Noguchi H, Nawata A, Nishii H, Guo X, et al. Coincidence between malignant perivascular epithelioid cell tumor arising in the gastric serosa and lung adenocarcinoma. World J Gastroenterol. 2015;21:1349-56 pubmed 出版商
  53. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed 出版商
  54. Moser B, Schiefer A, Janik S, Marx A, Prosch H, Pohl W, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541-8 pubmed 出版商
  55. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed 出版商
  56. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  57. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed 出版商
  58. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed 出版商
  59. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed 出版商
  60. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  61. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed 出版商
  62. Abdelzaher E, Abdallah D. Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int. 2014;2014:968794 pubmed 出版商
  63. Woodward W, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, et al. Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells. J Cancer. 2014;5:360-7 pubmed 出版商
  64. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features. Oncol Lett. 2014;7:65-68 pubmed
  65. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed 出版商
  66. Yasuno K, Nishiyama S, Kobayashi R, Yoshimura H, Takahashi K, Omachi T, et al. Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples. J Comp Pathol. 2014;150:18-26 pubmed 出版商
  67. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed 出版商
  68. Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed 出版商
  69. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed 出版商
  70. Andres R, Pajares I, Balmana J, Llort G, Ramon Y Cajal T, Chirivella I, et al. Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC). Clin Transl Oncol. 2014;16:280-4 pubmed 出版商
  71. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed 出版商
  72. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed 出版商
  73. Holt B, Betz D, Ford T, Beck J, BLOEBAUM R, Jeyapalina S. Pig dorsum model for examining impaired wound healing at the skin-implant interface of percutaneous devices. J Mater Sci Mater Med. 2013;24:2181-93 pubmed 出版商
  74. Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  75. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed 出版商
  76. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed 出版商
  77. Blanchard A, Ma X, Dueck K, Penner C, Cooper S, Mulhall D, et al. Claudin 1 expression in basal-like breast cancer is related to patient age. BMC Cancer. 2013;13:268 pubmed 出版商
  78. Farley A, Morris L, Vroegindeweij E, Depreter M, Vaidya H, Stenhouse F, et al. Dynamics of thymus organogenesis and colonization in early human development. Development. 2013;140:2015-26 pubmed 出版商
  79. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed 出版商
  80. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed 出版商
  81. Beha G, Brunetti B, Asproni P, Muscatello L, Millanta F, Poli A, et al. Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?. BMC Vet Res. 2012;8:219 pubmed 出版商
  82. Beha G, Sarli G, Brunetti B, Sassi F, Ferrara D, Benazzi C. Morphology of the myoepithelial cell: immunohistochemical characterization from resting to motile phase. ScientificWorldJournal. 2012;2012:252034 pubmed 出版商
  83. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  84. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed 出版商
  85. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed 出版商
  86. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed 出版商
  87. Ingthorsson S, Halldorsson T, Sigurdsson V, Friðriksdottir A, Bodvarsdottir S, Steinarsdottir M, et al. Selection for EGFR gene amplification in a breast epithelial cell line with basal-like phenotype and hereditary background. In Vitro Cell Dev Biol Anim. 2011;47:139-48 pubmed 出版商
  88. Baydar D, Kulac I, Gurel B, De Marzo A. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis. Int J Surg Pathol. 2011;19:131-6 pubmed 出版商
  89. Perrone F, Jocollè G, Pennati M, Deraco M, Baratti D, Brich S, et al. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. Eur J Cancer. 2010;46:2837-48 pubmed 出版商
  90. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed 出版商
  91. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed 出版商
  92. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed 出版商
  93. Blind C, Koepenik A, Pacyna Gengelbach M, Fernahl G, Deutschmann N, Dietel M, et al. Antigenicity testing by immunohistochemistry after tissue oxidation. J Clin Pathol. 2008;61:79-83 pubmed
  94. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  95. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  96. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  97. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed